Published in J Natl Cancer Inst Monogr on January 01, 2000
Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res (2006) 3.62
Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat (2013) 2.07
Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a molecular switch for complex disassembly. Mol Cell Biol (2006) 1.94
Transplacental arsenic carcinogenesis in mice. Toxicol Appl Pharmacol (2007) 1.86
Liver is a target of arsenic carcinogenesis. Toxicol Sci (2008) 1.55
Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. Breast Cancer Res (2006) 1.50
Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells. Cancer Prev Res (Phila) (2008) 1.26
Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers. Future Oncol (2010) 1.18
Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer. Mol Cancer (2013) 1.17
Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study. BMC Med (2006) 1.08
Oral contraceptive use and estrogen/progesterone receptor-negative breast cancer among African American women. Cancer Epidemiol Biomarkers Prev (2010) 1.08
Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells. J Steroid Biochem Mol Biol (2009) 1.04
Circulating sex steroids and breast cancer risk in premenopausal women. Horm Cancer (2010) 1.03
The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity. Mol Aspects Med (2013) 0.96
Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells. Breast Cancer Res (2007) 0.92
Morphologic transformation of human breast epithelial cells MCF-10A: dependence on an oxidative microenvironment and estrogen/epidermal growth factor receptors. Cancer Cell Int (2010) 0.91
Serum organochlorines and breast cancer: a case-control study among African-American women. Cancer Causes Control (2007) 0.90
Structural basis for Ca2+-induced activation and dimerization of estrogen receptor α by calmodulin. J Biol Chem (2012) 0.90
Circulating sex hormones and terminal duct lobular unit involution of the normal breast. Cancer Epidemiol Biomarkers Prev (2014) 0.88
Arsenic-induced aberrant gene expression in fetal mouse primary liver-cell cultures. Ann N Y Acad Sci (2008) 0.85
Current perspectives between metabolic syndrome and cancer. Oncotarget (2016) 0.84
Estrogen receptor positive breast cancers and their association with environmental factors. Int J Health Geogr (2011) 0.83
Reproductive and exogenous hormone factors in relation to risk of meningioma in women: a meta-analysis. PLoS One (2013) 0.83
The etiology and prevention of breast cancer. Drug Discov Today Dis Mech (2012) 0.83
Arsenic abrogates the estrogen-signaling pathway in the rat uterus. Reprod Biol Endocrinol (2010) 0.82
The Proliferative Activity of Mammary Epithelial Cells in Normal Tissue Predicts Breast Cancer Risk in Premenopausal Women. Cancer Res (2016) 0.81
Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models. Ann N Y Acad Sci (2011) 0.81
Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death. Steroids (2007) 0.81
Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer. Breast Cancer Res (2011) 0.81
Depurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer prevention. Clin Transl Med (2016) 0.79
Estrogen enhances the efficacy of an oncolytic HSV-1 mutant in the treatment of estrogen receptor-positive breast cancer. Int J Oncol (2006) 0.79
Dietary fat, tamoxifen use and circulating sex hormones in postmenopausal breast cancer survivors. Nutr Cancer (2010) 0.77
Inhibition of estrogen-induced mammary tumor formation in MMTV-aromatase transgenic mice by 4-chlorophenylacetate. Cancer Lett (2007) 0.77
Reduced risk of breast cancer associated with recreational physical activity varies by HER2 status. Cancer Med (2015) 0.77
Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis. Breast Cancer Res (2017) 0.77
Synthesis and evaluation of 11β-(4-substituted phenyl) estradiol analogs: transition from estrogen receptor agonists to antagonists. Bioorg Med Chem (2012) 0.76
Janus-faces of NME-oncoprotein interactions. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.75
Chemoprevention of Rat Mammary Carcinogenesis by Apiaceae Spices. Int J Mol Sci (2017) 0.75
Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells. PLoS One (2017) 0.75
Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res (2000) 1.55
A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens. Environ Health Perspect (1998) 1.55
Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer Res (1998) 1.44
Regulation of epidermal growth factor receptor by estrogen. J Biol Chem (1985) 1.32
Estrogen regulation of c-fos messenger ribonucleic acid. Mol Endocrinol (1988) 1.22
Estrogen regulation of epidermal growth factor receptor messenger ribonucleic acid. Mol Endocrinol (1988) 1.12
Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen. Cancer Res (1996) 1.10
Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environ Health Perspect (2000) 1.07
Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins. Mol Endocrinol (1999) 1.06
Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells. Int J Cancer (2001) 1.05
Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780. Cancer Res (1997) 0.97
Reversible dissociation of yeast glyceraldehyde 3-phosphate dehydrogenase by adenosine triphosphate. Biochemistry (1969) 0.96
DDT supports the growth of an estrogen-responsive tumor. Toxicol Lett (1985) 0.96
The protooncogene c-jun contains an unusual estrogen-inducible enhancer within the coding sequence. J Biol Chem (1995) 0.94
Regulation of uterine epidermal growth factor (EGF) receptors by estrogen in the mature rat and during the estrous cycle. J Steroid Biochem (1989) 0.93
Interaction of human estrogen receptors alpha and beta with the same naturally occurring estrogen response elements. Biochem Pharmacol (1999) 0.93
Hormonal control of transcription in the rat uterus. Stimulation of deoxyribonucleic acid-dependent RNA polymerase III by estradiol. J Biol Chem (1977) 0.91
Progesterone inhibits the estrogen-induced expression of c-fos messenger ribonucleic acid in the uterus. Endocrinology (1992) 0.91
Receptors for epidermal growth factor in the rat uterus. Endocrinology (1985) 0.90
Regulation of VEGF in the reproductive tract by sex-steroid hormones. Histol Histopathol (2000) 0.88
Steroid hormone-induced expression of oncogene encoded nuclear proteins. Crit Rev Eukaryot Gene Expr (1994) 0.88
Estrogenic activity of DDT: estrogen-receptor profiles and the responses of individual uterine cell types following o,p'-DDT administration. J Toxicol Environ Health (1985) 0.88
Estrogen receptors in the rat uterus. Multiple forms produced by concentration-dependent aggregation. Biochemistry (1973) 0.88
Contractions of the isolated uterus stimulated by epidermal growth factor. FASEB J (1987) 0.87
Identification of an estrogen response element in the 3'-flanking region of the murine c-fos protooncogene. J Biol Chem (1992) 0.87
Most of the G1 period in hamster cells is eliminated by lengthening the S period. Proc Natl Acad Sci U S A (1981) 0.87
The pure antiestrogen ICI 182,780 inhibits progestin-induced transcription. Cancer Res (1999) 0.85
Synthetic estrogen 17alpha-ethinyl estradiol induces pattern of uterine gene expression similar to endogenous estrogen 17beta-estradiol. J Pharmacol Exp Ther (1999) 0.85
Activation of mammalian cyclic AMP phosphodiesterases by trypsin. Biochim Biophys Acta (1978) 0.84
Estrogen regulates expression of the jun family of protooncogenes in the uterus. J Steroid Biochem Mol Biol (1992) 0.83
Evidence for thyroid hormone receptors in uterine nuclei. Metabolism (1983) 0.83
The influence of sex hormones on antidepressant-induced alterations in neurotransmitter receptor binding. J Neurosci (1982) 0.82
The effect of hypophysectomy on the uterine response to estradiol. Endocrinology (1977) 0.82
Stimulatory and inhibitory effects of estrogen and antiestrogen on uterine cell division. Endocrinology (1981) 0.81
Presence of an estradiol response region in the mouse c-fos oncogene. Steroids (1991) 0.81
Regulation of the uterine response to estrogen by thyroid hormone. Endocrinology (1978) 0.81
Analysis of cytoplasmic and nuclear estrogen-receptor proteins by sucrose density gradient centrifugation. Methods Enzymol (1975) 0.80
Induction of the angiogenic factor VEGF in the uterus by the antiprogestin onapristone. Cancer Lett (2000) 0.80
Triphenylethylene antiestrogens induce uterine vascular endothelial growth factor expression via their partial estrogen agonist activity. Cancer Lett (1997) 0.80
Anti-invasion drugs. Breast Cancer Res Treat (1996) 0.80
Estrogen receptors in the rat uterus. Relationship between cytoplasmic and nuclear forms of the estrogen binding protein. Biochemistry (1973) 0.80
Imipramine: effect of ovarian steroids on modifications in serotonin receptor binding. Science (1981) 0.80
Elevation of protooncogene messenger RNAs in estrogen-induced kidney tumors in the hamster. Carcinogenesis (1992) 0.80
Retinoic acid inhibits estrogen-induced uterine stromal and myometrial cell proliferation. Endocrinology (1995) 0.79
Evidence for convertible forms of soluble uterine cyclic nucleotide phosphodiesterase. Biochim Biophys Acta (1981) 0.79
Tamoxifen stimulates expression of the c-fos proto-oncogene in rodent uterus. Mol Pharmacol (1993) 0.79
Hormonal carcinogenesis: separation of estrogenicity from carcinogenicity. Chem Biol Interact (1986) 0.79
Separation of multiple forms of cyclic nucleotide phosphodiesterases from rat brain by isoelectrofocusing. Biochim Biophys Acta (1974) 0.79
Cultured human uterine smooth muscle cells are retinoid responsive. Proc Soc Exp Biol Med (1997) 0.79
Oncogenes and uterine function. Oxf Rev Reprod Biol (1993) 0.79
Effects of estrogen on mitosis in individual cell types of the immature rat uterus. Biol Reprod (1979) 0.78
Decreased cell division of the uterine luminal epithelium of diabetic rats in response to 17 beta-estradiol. Endocrinology (1981) 0.78
In vitro interaction of uterine estrogen receptor with the estrogen response element present in the 3'-flanking region of the murine c-fos protooncogene. J Steroid Biochem Mol Biol (1994) 0.78
Stimulation of uterine deoxyribonucleic acid synthesis by 1,1,1-trichloro-2-(p-chlorophenyl)-2-(o-chlorophenyl)ethane (o,p'-DDT). Biochem Pharmacol (1980) 0.78
Effect of a diabetic state on myometrial ultrastructure and isolated uterine contractions in the rat. Proc Soc Exp Biol Med (1985) 0.78
Hormonal control of uterine growth: alterations in luminal epithelial deoxyribonucleic acid synthesis after intraluminal application of estrogen. Endocrinology (1984) 0.78
The estrogenic activity of DDT: in vivo and in vitro induction of a specific estrogen inducible uterine protein by o,p'-DDT. Life Sci (1980) 0.78
The estrogenic activity of DDT: correlation of estrogenic effect with nuclear level of estrogen receptor. Life Sci (1982) 0.78
An approach to the development of quantitative models to assess the effects of exposure to environmentally relevant levels of endocrine disruptors on homeostasis in adults. Environ Health Perspect (1999) 0.77
Autoradiographic localization of epidermal growth factor receptors to all major uterine cell types. Biol Reprod (1988) 0.77
Estrogen action in target cells: selective requirements for activation of different hormone response elements. Mol Cell Endocrinol (1995) 0.77
Characterization of soluble uterine cyclic nucleotide phosphodiesterase. Biochemistry (1978) 0.77
The estrogenic activity of DDT: the in vitro induction of an estrogen-inducible protein by o,p'-DDT. Toxicol Appl Pharmacol (1984) 0.77
Selective blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine. Endocrinology (1978) 0.76
Cellular pattern of c-fos induction by estradiol in the immature rat uterus. Biol Reprod (1995) 0.76
Neonatal exposure to diethylstilbestrol permanently alters the basal and 17 beta-estradiol induced expression of c-fos proto-oncogene in mouse urethroprostatic complex. Mol Cell Endocrinol (1997) 0.75
Hormonal control of uterine growth: the effect of hypothyroidism on estrogen-stimulated cell division. Endocrinology (1981) 0.75
Binding and function of serotonin 2 receptors following chronic administration of imipramine. Neuropharmacology (1984) 0.75
Regulation of deoxyribonucleic acid polymerase activity in uterine luminal epithelium after multiple doses of estrogen. Endocrinology (1988) 0.75
Hormonal control of uterine growth: temporal relationships between estrogen administration and deoxyribonucleic acid synthesis. Endocrinology (1982) 0.75
Metabolic control and structure of glycolytic enzymes. V. Dissociation of yeast glyceraldehyde-3-phosphate dehydrogenase into subunits by ATP. Biochem Biophys Res Commun (1968) 0.75
Effects of experimentally-induced diabetes on oestradiol-stimulated changes in the ultrastructure of the rat endometrium. Acta Endocrinol (Copenh) (1985) 0.75
Creation of an active estrogen-responsive element by a single base change in the flanking sequence of a cellular oncogene: a possible mechanism for hormonal carcinogenesis? Mol Carcinog (1993) 0.75
The 3-flanking region of the mouse c-fos gene contains a cluster of GGTCA hormone response-like elements. Mol Biol Rep (1998) 0.75
Phorbol ester inhibition of estrogen-induced uterine deoxyribonucleic acid synthesis. Biol Reprod (1998) 0.75
The influence of hormones on drug-induced modifications in neurotransmitter receptor binding. Prog Clin Biol Res (1982) 0.75
Blockade of epidermal growth factor-induced uterine contractions by indomethacin or nordihydroguaritic acid. J Pharmacol Exp Ther (1989) 0.75
Progesterone inhibits estrogen-induced increases in c-fos mRNA levels in the uterus. Recent Prog Horm Res (1993) 0.75
Estrogen receptors in the rat uterus. Retention of hormone-receptor complexes. Biochemistry (1976) 0.75
Effect of ovariectomy and estrogen treatment on uterine benzylamine oxidase and monoamine oxidase type A. Res Commun Chem Pathol Pharmacol (1983) 0.75
Cyclic nucleotide phosphodiesterases in uterine development. Mol Cell Endocrinol (1975) 0.75